Literaturverzeichnis

Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the modell and development of a neurologic examination. Stroke 17: 472-476

Berlit P (2000) Schlaganfall. Nervenarzt 71: 231-237

Bronner LL, Kanter DS, Manson JE (1995) Primary prevention of stroke. N Engl J Med 333: 1392-1400

Carro E, Nunez A, Busiguina S, Torres-Aleman I (2000) Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neuroscience 20: 2926-2933

Crouse JR III, Byington RP, Furberg CD (1998) HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis 138: 11-24

Delanty N, Vaughan CJ (1997) Vascular effects of statins in stroke. Stroke 28: 2315-2320

Endres M, Laufs U, Liao KL, Moskowitz MA (2004) Targeting eNOS for stroke protection. Trends Neurosci 27: 283-289

Endres M, Laufs U, Huang Z, Nakamura T, Huang PL, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. PNAS 95: 8880-8885

Freedman JE, Sauter R, Battinelli EK, Ault K, Knowles C, Huang PL, Loscalso J (1999) Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOS III gene. Circ Res 84: 1416-1421

Freedman JE, Loscalso J, Barnard MR, Alpert C, Keaney JF Jr, Michelson AD (1997) Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100: 350-356

Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376

Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343: 425-343

Haberl RL, Dembowski K (1999) Atherothrombosis: common factor in stroke, myocardial infarction and peripheral vascular disease. Eur Heart J 1: A41-A44

Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence D, Doig G, Wolfe BM (1996) Lipids and stroke: a paradox resolved. Arch Neurol 53: 303-308

Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514

Haylor J, Singh I, el Nahas AM (1991) Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 39: 333-335

Hebert PR, Gaziano JM, Chan KS, Hennekens CH (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomised trials. JAMA 278: 313-321

Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105: 1446-1452

Hornig B, Maier V, Drexler H (1996) Physical training improves endothelial function in patients with chronic heart failure. Circulation 93: 210-214

Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242

Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16: 981-987

Iadecola C (1997) Bright and dark sides of nitric oxide in ischaemic brain injury. Trends Neurosci 20: 132-139

Jay TM, Lucignani G, Crane AM, Jehle J, Sokoloff L (1988) Measurement of local cerebral blood flow with [14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab 8: 121-129

Kaplan KL, Owen J (1981) Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57: 199-202

Kearney D, Fitzgerald D (1999) The anti-thrombotic effects of statins. J Am Coll Cardiol 33: 1305-1307

Knopp RH (1999) Drug treatment of lipid disorders. N Engl J Med 341: 498-511

Kröncke KD, Fehsel K, Suschek C, Kolb-Bachofen V (2001) Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 1: 1407-1420

Laufs U, La Fata V, Plutzky J, Liao JK (1998a) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135

Laufs U, Liao JK (1998b) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271

Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102: 3104-3110

Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickenig G (2001) Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 88: 1306-1307

Lee IM. Hennekens CH, Berger K, Buring JE, Manson JE (1999) Exercise and Risk of Stroke in Male Physicians. Stroke 30: 1-6

Libby P, Sukhova G, Lee RT, Liao JK (1997) Molecular biology of atherosclerosis. Int J Cardiol 62: S23-S29

Lindauer U, Kunz A, Schuh-Hofer S, Vogt J, Dreier JP, Dirnagl U (2001) Nitric oxide from perivascular nerves modulates cerebral arterial pH reactivity. Am J Physiol 281: H1353-H1363

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. (1998) The Long Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 339: 1349-1357

Loscalzo J (1995) Nitric oxide and vascular disease. N Engl J Med 333: 251-253

Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T (1994) L-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25: 429-435

Neeper SA, Gomez-Pinilla G, Choi J, Cotman C (1995) Exercise and brain neurotrophins. Nature 373: 109

Nezasa K, Higaki K, Matsumura T, Inazawa K, Hasegawa H, Nakano M, Koike M (2002) Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin. Drug Metab Dispos 30: 1158-1163

Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287-1294

Radomski MW, Palmer RM, Moncada S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. PNAS 87: 5193-5197

Sacco RL, Gan R, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC (1998) Leisure-Time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 29: 380-387

Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J med 335: 1001-1009

Sase K, Michel T (1995) Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 57: 2049-2055

Sessa WC, Pritchard K, Seyedi M, Wang J, Hintze TH (1994) Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74: 349-353

Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA (1995) Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol 26: 339-342

Stummer W, Baethmann A, Murr R, Schurer L, Kempski OS (1995) Cerebral protection against ischemia by locomotor activity in gerbils. Stroke 26: 1423-1430

Thomas M, Mann J (1998) Increased thrombotic vascular events after change of statin. Lancet 352: 1830-1831

Tong L, Shen H, Perreau VM, Balazs R, Cotman CW (2001) Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Diss 8: 1046-1056

Vaughan CJ, Murphy MB, Buckley BM (1996) Statins do more than just lower cholesterol. Lancet 348: 1079-1082

Vaughan CJ, Delanty N (1999) Neuroprotective properties of statins in cerebral ischemia and stroke. 30: 1969-1973

Van Praag H, Christie BR, Sejnowski TJ, Gage FH (1999) Running enhances neurogenesis, learning, and long-term potentiation in mice. PNAS 96: 13427-13431

Werner N, Nickenig G, Laufs U (2002) Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97: 105-116

Wollny T, Aiello L, Di Tommaso D, Bellavia V, Rotilio D, Donati MB, de Gaetano G, Iacoviello L (1999) Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production. Br J Pharmacol 127: 747-755